Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Hangzhou Jiuyuan Gene Engineering Co. Ltd.,.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Information provided by (Responsible Party):
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
ClinicalTrials.gov Identifier:
NCT01637493
First received: July 2, 2012
Last updated: July 10, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)